Is Pfizer Rapamune being discontinued? A guide for patients
•
5 min read
As of December 31, 2023, Pfizer officially discontinued its brand-name drug Rapamune® in the United States, informing the Lymphangioleiomyomatosis (LAM) Foundation and healthcare providers. This decision impacts patients relying on the brand-name product, requiring them to transition to a generic equivalent, sirolimus.